Dr. Mamoo Nakamura, MD

Dr. Nakamura practices at Cedars-Sinai Medical Center in Los Angeles, California, part of Cedars-Sinai Health System.

Dr. Nakamura's NPI, 1972752467, was assigned on September 9, 2008. Dr. Nakamura holds California license A115062.

Dr. Nakamura's primary practice is Cedars-Sinai Medical Center, at 8700 Beverly Blvd, Los Angeles, CA 90048 in Los Angeles County. The practice phone is (310) 423-5000.

Dr. Nakamura's primary practice is Cedars-Sinai Medical Center in Los Angeles, California, part of Cedars-Sinai Health System. The medical group on file is Cedars-Sinai Medical Center. Dmand AI also links Dr. Nakamura to 1 more medical group, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Nakamura practices. Vendor and product names are available with a free account.

Interventional cardiology is Dr. Nakamura's primary specialty in the NPI Registry, under taxonomy code 207RI0011X. Dmand AI has Dr. Nakamura's licenses on file in 2 states: California and Florida.

CMS data shows 1,148 Medicare services from Dr. Nakamura across 20 procedure codes in 2024, for 680 Medicare patients. Medicare paid $315,196 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 680 Medicare patients who saw Dr. Nakamura in 2024. The largest group is 65 to 74, with 274 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 39% are also on Medicaid. Their average risk score is 2.59, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Nakamura's median patient age at 71, with 36% women.

In 2024, Dr. Nakamura wrote 182 Medicare Part D claims for 94 patients. 93% of them were for generic drugs. CMS names the drug for 127 of them, across 1 drug with 11 or more claims each, at $1,500 in total drug cost. In 2023, CMS named 141 claims across 2 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 93 out of 100 for Dr. Nakamura for performance year 2024, reported as part of a group. Dr. Nakamura accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Nakamura as offering telehealth. CMS counts 236 procedures of coronary angioplasty and stenting by Dr. Nakamura, more than 99% of the clinicians it reports for that procedure.

Pacemaker insertion or repair: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 47 papers to Dr. Nakamura, published from 2012 to 2025. 2020 was the busiest year, with 6. The most frequent topics are Transcatheter Aortic Valve Replacement, Aortic Valve and Aortic Valve Stenosis. Dr. Nakamura has published most often in EuroIntervention. Dr. Nakamura's most frequent co-authors are Tarun Chakravarty, MD, Raj R. Makkar, MD and Sharjeel Israr, MD.

Dmand AI links Dr. Nakamura to 5 clinical trials. 3 are still active or recruiting. Conditions studied include Gastroesophageal Reflux, Mitral Valve Insufficiency and Tricuspid Valve Insufficiency. Edwards Lifesciences sponsors the most, 4.

CMS Open Payments shows 895 general payments to Dr. Nakamura from 16 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 52% of the total. Abbott Laboratories paid the most, $165,663.